PLoS ONE, 2021 Background Vulvovaginal candidiasis is a common superficial candidiasis; however, a host’s immunological mechanism against vaginal Candida infection remains unknown.
Masahiro Abe +6 more
doaj +2 more sources
β-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasis. [PDF]
PLoS ONE, 2014 Vulvovaginal candidiasis (VVC) is among the most prevalent vaginal diseases. Candida albicans is still the most prevalent species associated with this pathology, however, the prevalence of other Candida species, such as C. glabrata, is increasing.
Patricia de Souza Bonfim-Mendonça +9 more
doaj +1 more source
Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
Journal of Fungi, 2020 Candida albicans, along with other closely related Candida species, are the primary causative agents of vulvovaginal candidiasis (VVC)—a multifactorial infectious disease of the lower female reproductive tract resulting in pathologic inflammation. Unlike
H. Willems +4 more
semanticscholar +1 more source
Rational treatment for vulvovaginal candidiasis caused by resistant Candida species [PDF]
РМЖ. Мать и дитя, 2019 G.B. Dikke F.I. Inozemtsev Academy of Medical Education, St. Petersburg, Russian Federation In recent decade, growing incidence (24–29%) of vulvovaginal candidiasis caused by Candida non-albicans is reported.
G.B. Dikke
doaj
Antioxidants, 2022 Vulvovaginal candidiasis (VVC) is one of the most frequent diseases induced by Candida albicans (C. albicans) during pregnancy, which results in enormous pain to women and their partners in daily life.
Lei Chen +10 more
semanticscholar +1 more source
Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study. [PDF]
PLoS ONE, 2018 OBJECTIVE:To characterize the lipid profile in vaginal discharge of women with vulvovaginal candidiasis, cytolytic vaginosis, or no vaginal infection or dysbiosis. DESIGN:Cross-sectional study.
José Marcos Sanches +8 more
doaj +1 more source
Clinical case: patient treated for vulvovaginal candidiasis
Клинический разбор в общей медицине, 2021 Case study of acute vulvovaginal candidiasis treated with medication containing dequalinium chloride as an active ingredient has been reported. Patient A.
Tatyana Yu. Pestrikova
doaj +1 more source
Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306
Journal of Women's Health, 2022 Background: Ibrexafungerp is a novel antifungal treatment for acute vulvovaginal candidiasis (VVC). Using pooled data from two phase three studies (VANISH 303 and 306) in the treatment of acute VVC, this analysis sought to determine the effectiveness of ...
O. Goje +10 more
semanticscholar +1 more source
Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy [PDF]
РМЖ. Мать и дитя, 2018 Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N. National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.
Kan N.E., Lomova N.A., Kokoeva D.N.
doaj
Comparison of Single Dose Sertaconazole versus Three Dose Clotrimazole Regime in Treatment of Uncomplicated Vulvovaginal Candidiasis- A Prospective Study [PDF]
Journal of Clinical and Diagnostic Research, 2019 Introduction: Vulvovaginal candidiasis is the second most common vaginitis following bacterial vaginitis amongst the reproductive age group with variable compliance to the treatment.
Katha Desai, Pradip Sambarey
doaj +1 more source